Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Abstract Centers for Medicare and Medicaid Services (CMS) administrative data are among the most practical sources for understanding the incidence of dementia over time in older populations, but have yet to be widely used in intervention studies. Through the National Institute of Aging’s LINKAGE program, the Baltimore Experience Corps Trial (2006-2022) is one of the first intervention studies to leverage Maryland’s state-level Health Information Exchange (HIE) (2013-2022) data, along with CMS administrative data (2008-2022) to sensitively capture participants’ healthcare utilization. After evaluating multiple established dementia classification algorithms, we used the Bynum evaluation and management (Bynum-EM) algorithm to identify dementia using International Classification of Diseases (ICD-9,10) codes from CMS Fee-for-Service, Medicare Advantage, and HIE data. We further adjudicated dementia diagnosis by its subtypes (Alzheimer’s, mixed/vascular) and incorporated dementia-free mortality. Of 702 participants, 520 were successfully linked with CMS/HIE administrative data. These linked participants were predominantly female (84%), Black (95%), with an average age of 68±6 years and an average of two comorbidities. Over the 14-year follow-up, 26% (n = 135) of the BECT cohort developed dementia, with 8% (n = 32) of them diagnosed with vascular or mixed dementia. About 44% (n = 230) of participants died over time, with 27% having dementia-free mortality. Our study demonstrated the value of both CMS Medicare and state-level HIE data in classifying incident dementia and its subtypes among older adults, providing a useful approach to evaluating long-term intervention effects on dementia risk without requiring in-person follow-up.

Key findings

Why it matters

Using CMS and Maryland health information exchange data, 26% of 520 linked trial participants developed dementia over 14 years, showing that administrative data can classify incident dementia and its subtypes without in-person follow-up. This is a methods finding about tracking dementia in intervention studies, not a treatment, cure or prevention result.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Innovation in Aging)
Journal's citation record 0 / 4 Innovation in Aging: journal h-index 48 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 135 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Michelle C. Carlson: h-index 59 (OpenAlex, whole career)
Institution's track record 2 / 3 Johns Hopkins University: institution h-index 2,306 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Sekhon, V., Xue, Q., Moored, K., Amjad, H., Richards, E., Slade, E. P., et al. (2025). Classifying Dementia Diagnoses in the Baltimore Experience Corps Trial Using Medicare and Maryland’s Health Data. Innovation in Aging. https://doi.org/10.1093/geroni/igaf122.3560

Vancouver

Sekhon V, Xue Q, Moored K, Amjad H, Richards E, Slade EP, et al. Classifying Dementia Diagnoses in the Baltimore Experience Corps Trial Using Medicare and Maryland’s Health Data. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.3560.

BibTeX

@article{sekhon2025-e26227ab,
  author  = {Sekhon, Vishaldeep and Xue, Qian‐Li and Moored, Kyle and Amjad, Halima and Richards, Emily and Slade, Eric P. and Rebok, George and Carlson, Michelle C.},
  title   = {{Classifying Dementia Diagnoses in the Baltimore Experience Corps Trial Using Medicare and Maryland’s Health Data}},
  journal = {Innovation in Aging},
  year    = {2025},
  doi     = {10.1093/geroni/igaf122.3560},
  url     = {https://doi.org/10.1093/geroni/igaf122.3560}
}

Related studies in Health systems and care delivery

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →